CapIQ

Source: S&P Capital IQ consensus via Xpressfeed · Generated 2026-08-03.

Consensus Tape

The consensus is bullish and still rising for the near year. All 13 covering analysts rate Japfa Buy or Outperform, and FY2027 estimates have been revised up over the past six months — revenue by about 7% and normalized EPS by about 9.6%. Reported revenue has topped consensus in each of the last two quarters by roughly 7%. The caution sits in the outer years, where coverage thins and estimates scatter widely.

Source: derived from vendor data.

FY2027 estimates have climbed all year

The clearest signal in the tape is direction, not level: the next full year keeps getting marked up. Over the six months to early August, the FY2027 revenue consensus rose from 66,017 to 70,606 (IDR bn), about 7%; normalized EPS for the same year moved from 370 to 406, up roughly 9.6%. The path is a steady climb rather than one jump — each snapshot sits above the last.

Source: derived from vendor data.

The upgrade is concentrated in the near year. FY2028 consensus has barely moved — revenue sits at 77,766 (IDR bn) against 78,137 three months earlier, and normalized EPS at 424 against 415. The revision cycle is real but shallow-dated: analysts are marking up what they can see, and holding the rest.

Revenue keeps beating the number, lately by about 7%

Reported revenue has come in ahead of the consensus captured just before each print in three of the last four quarters on record, and the two most recent prints are the strongest — each about 7% above consensus. The only recent shortfall was Q2 FY2024. Going further back, revenue also beat in Q4 FY2023 (6.8%) and Q3 FY2022 (3.1%), with mixed results in earlier years. Surprises of this size and sign read as conservative guidance rather than genuine volatility.

Source: derived from vendor data.

Consensus growth: revenue accelerating, EPS cooling

Consensus has revenue growing close to 8% in FY2026 (7.9%) and FY2027 (7.8%), then accelerating to about 10.1% in FY2028, reaching roughly 77,766 (IDR bn). Normalized EPS follows a different curve: up about 11.4% in FY2026 off the strong FY2025 actual of 344, then cooling to about 5.9% and 4.6% in the two years after. The message is that later-year earnings depend on margins holding, not on volume alone.

Source: derived from vendor data. FY2025 is the reported actual; later years are consensus.

Outer-year estimates scatter, and rest on few analysts

Disagreement widens sharply the further out you look. For FY2028 the normalized-EPS estimates run from 230 at the low to 520 at the high — more than double — on just 8 contributing analysts. FY2027 is tighter, 370 to 477 across 10 analysts. One detail helps explain the persistent upward drift: the FY2025 actual of 344 landed above the highest FY2025 estimate of 338, so the near-year numbers have been chasing a company that keeps out-running them.

Source: derived from vendor data.

Every covering analyst rates it Buy or Outperform

Positioning is uniformly positive. All 13 analysts with a recommendation rate Japfa Buy (11) or Outperform (2); none are neutral or negative. Price targets run from 2,450 to 3,700, with a mean of 3,113 and a median of 3,200 — a spread wide enough to matter, but centred well above the low. This source carries no current share price, so no implied upside is stated here.

Source: derived from vendor data.